Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Mol Cell Endocrinol ; 518: 110970, 2020 12 01.
Article in English | MEDLINE | ID: mdl-32738443

ABSTRACT

White adipose tissue (WAT) browning is a potential strategy to treat obesity, and is characterized by the formation of brown adipocytes induced by cold or ß-3 adrenergic receptor (ß-3AR) agonist treatment. The hedgehog (Hh) signaling at the primary cilium is closely related to obesity, and plays a key role in the differentiation and adipogenesis of adipocytes. However, little is known about its effects on WAT browning. In this study, browning models were used to evaluate the activity and effect of Hh signaling on WAT browning using Hh antagonists, agonist, and small-interfering RNAs (siRNAs) specific for glioma-associated oncogene homologue 1 (Gli1), smoothened (Smo), and suppressor of fused (Sufu). We observed that Hh signaling activity was inhibited during the browning process both in vivo and in vitro. Further, Hh signaling inhibition enhanced WAT browning, while its activation attenuated norepinephrine-induced browning. Thus, the inhibition of Hh signaling promotes WAT browning and therefore, Hh signaling may be a therapeutic target against obesity and associated comorbidities.


Subject(s)
Adipocytes/cytology , Adipose Tissue, Brown/metabolism , Adipose Tissue, White/metabolism , Dioxoles/pharmacology , Hedgehog Proteins/genetics , Adipocytes/drug effects , Adipocytes/metabolism , Adipogenesis , Animals , Cell Differentiation , Cold Temperature , Energy Metabolism , Gene Expression Regulation/drug effects , Hedgehog Proteins/metabolism , Humans , Male , Mice , Norepinephrine/pharmacology , Primary Cell Culture , Repressor Proteins/genetics , Signal Transduction/drug effects , Smoothened Receptor/genetics , Thermogenesis , Zinc Finger Protein GLI1/genetics
2.
Nutr Metab (Lond) ; 16: 88, 2019.
Article in English | MEDLINE | ID: mdl-31889968

ABSTRACT

BACKGROUND: Obesity is a global epidemic disease that increases the risk of metabolic syndrome. However, therapeutic drugs for obesity are still scarce. In recent years, peptides have been identified as new biological regulators. RIFV (R-I-F-V-P-I-K-G-R-P-A-P), a novel active peptide from our peptide database. METHODS: We performed oil red O staining and triglyceride measurement to analyze the influence of RIFV on white preadipocytes differentiation. Then the effects of RIFV on cell proliferation, apoptosis and cell cycle were determined by using CCK-8 assay and flow cytometry. The mRNA and protein levels of adipogenesis-related genes were respectively detected by qRT-PCR and western blot. Rescue experiment was conducted to confirm whether RIFV could regulate adipocytes differentiation via targeting C/EBP-ß. Finally, the luciferase reporter gene assay was performed to verify the regulation of RIFV on C/EBP-ß gene. RESULTS: RIFV was revealed to inhibit the differentiation of human white adipocytes without affecting their proliferation. Additionally, RIFV could also suppress the differentiation of mouse primary white preadipocytes isolated from inguinal fat tissues. Furthermore, RIFV may have an inhibitory effect on adipogenesis by inhibiting the regulation of the adipogenic gene C/EBP-ß. CONCLUSIONS: Our results indicated that RIFV may be a novel essential regulator of adipocyte differentiation and represents a therapeutic strategy for obesity and related complications.

3.
Biochim Biophys Acta Gene Regul Mech ; 1861(2): 125-132, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29391195

ABSTRACT

The novel obesity-associated protein Phosphotyrosine Interaction Domain containing 1 (PID1) inhibits insulin-PI3K/Akt signaling pathway and insulin-stimulated glucose uptake in vitro. In this study, we generated fat tissue-specific aP2-PID1 transgenic (aP2-PID1tg) mice and PID1 knockout (PID1-/-) mice to explore how PID1 affects glucose metabolism in vivo. We observed insulin resistance and impaired insulin-PI3K/Akt signaling in aP2-PID1tg mice. Consistent with these data, the PID1-/- mice displayed improved glucose tolerance and insulin sensitivity under chow diet, with increased Akt phosphorylation in white adipose tissue (WAT). We further demonstrated that PID1 could interact with low density lipoprotein receptor-related protein 1 (LRP1) but not the insulin receptor (IR) in adipocytes, and its overexpression could lead to decreased GLUT4 level. Our results thus indentify PID1 as a critical regulator of glucose metabolism in adipocytes.


Subject(s)
Adipocytes/metabolism , Carrier Proteins/metabolism , Glucose/metabolism , Homeostasis , 3T3-L1 Cells , Adipose Tissue, White/metabolism , Animals , Carrier Proteins/genetics , Fatty Acid-Binding Proteins/genetics , Fatty Acid-Binding Proteins/metabolism , Glucose Transporter Type 4/metabolism , Humans , Insulin/metabolism , Insulin Resistance , Low Density Lipoprotein Receptor-Related Protein-1 , Mice , Mice, Knockout , Mice, Transgenic , Phosphatidylinositol 3-Kinases/metabolism , Protein Binding , Receptors, LDL/metabolism , Tumor Suppressor Proteins/metabolism
4.
Cell Biochem Funct ; 34(5): 299-309, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27137150

ABSTRACT

Bronchopulmonary dysplasia (BPD) is a common complication of premature birth that seriously affects the survival rate and quality of life among preterm neonates. Long non-coding RNAs (lncRNAs) have been implicated in many human diseases. However, the role of lncRNAs in the pathogenesis of BPD remains poorly understood. Here, we exposed neonatal C57BL/6J mice to 95% concentrations of ambient oxygen and established a mouse lung injury model that mimicked human BPD. Next, we compared lncRNA and messenger RNA (mRNA) expression profiles between BPD and normal lung tissues using a high-throughput mouse lncRNA + mRNA array system. Compared with the control group, 882 lncRNAs were upregulated, and 887 lncRNAs were downregulated in BPD lung tissues. We validated some candidate BPD-associated lncRNAs by real-time quantitative reverse-transcription polymerase chain reaction analysis in eight pairs of BPD and normal lung tissues. Gene ontology, pathway and bioinformatics analyses revealed that a downregulated lncRNA, namely AK033210, associated with tenascin C may be involved in the pathogenesis of BPD. To the best of our knowledge, our study is the first to reveal differential lncRNA expression in BPD, which provides a foundation for further understanding of the molecular mechanism of BPD development. Copyright © 2016 John Wiley & Sons, Ltd.


Subject(s)
Bronchopulmonary Dysplasia/etiology , Bronchopulmonary Dysplasia/genetics , Gene Expression Profiling , Gene Expression Regulation , Hyperoxia/complications , RNA, Long Noncoding/genetics , Animals , Animals, Newborn , Biomarkers/metabolism , Computational Biology , Disease Models, Animal , Female , Gene Ontology , Lung/metabolism , Lung/pathology , Mice, Inbred C57BL , Oligonucleotide Array Sequence Analysis , RNA, Long Noncoding/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reproducibility of Results , Signal Transduction/genetics , Survival Analysis , Tenascin/genetics , Tenascin/metabolism
5.
Mol Genet Genomics ; 290(5): 1659-71, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25773316

ABSTRACT

Brown adipose tissue (BAT) functions to dissipate energy in response to cold exposure or overfeeding. Counteracting obesity has been extensively considered as a promising target. Long noncoding RNAs (lncRNAs) are an important class of pervasive genes involved in a variety of biological functions. However, the potential biological functions of lncRNAs during mouse brown fat cell differentiation have not been fully understood. Here, we performed lncRNA and mRNA expression profile analysis using microarray technology and identified 1064 lncRNAs with differential expression (fold change| ≥4, p ≤ 0.01) on day 0 and day 8 during differentiation. Furthermore, candidate lncRNAs were characterized by comprehensive examination of their genomic context, gene ontology (GO) enrichment of their associated protein-coding genes and pathway analysis. We identified three lncRNAs (Gm15051, Tmem189 and Cebpd) associated with their flanking coding genes (Hoxa1, C/EBPß and C/EBPδ), which participated in adipose commitment. Collectively, our findings indicated lncRNAs are involved in mouse BAT development and provide potential targets for obesity therapy.


Subject(s)
Adipocytes/cytology , Adipose Tissue, Brown/cytology , Cell Differentiation/genetics , RNA, Long Noncoding/physiology , Transcriptome , Animals , Gene Expression Profiling , Mice , Mice, Inbred C57BL , RNA, Long Noncoding/genetics , Real-Time Polymerase Chain Reaction , Transcription Factors/genetics
6.
Mol Immunol ; 59(1): 64-70, 2014 May.
Article in English | MEDLINE | ID: mdl-24491489

ABSTRACT

B cell activating factor (BAFF), a ligand belonging to the tumor necrosis factor (TNF) family is critical to B cell survival, proliferation, maturation and immunoglobulin secretion. In this study, the yellow grouper (Epinephelus awoara) BAFF (designated EaBAFF) gene was cloned using RT-PCR and RACE (rapid amplification of cDNA ends) techniques. The full-length EaBAFF was 1442bp and contained an open reading frame of 780bp encoding a putative protein of 259 amino acids. Amino acids sequence comparison indicated that EaBAFF possessed the TNF signature. The soluble BAFF (EasBAFF) had been cloned into pET28a. SDS-PAGE and Western blotting analysis confirmed that the soluble fusion protein His-EasBAFF was efficiently expressed in Escherichia coli BL21 (DE3). In vitro, the WST-8 assay indicated that EasBAFF was not only able to promote the survival/proliferation of yellow grouper splenic lymphocytes but also able to promote the survival/proliferation of mouse splenic B cells. Our findings may provide valuable information for research into the immune system of E. awoara and EasBAFF may serve as a potential immunologic factor for enhancing immunological efficacy in fish.


Subject(s)
B-Cell Activating Factor/genetics , Fish Proteins/genetics , Gene Expression , Perciformes/genetics , Amino Acid Sequence , Animals , B-Cell Activating Factor/classification , B-Cell Activating Factor/metabolism , B-Lymphocytes/metabolism , Blotting, Western , Cloning, Molecular , Fish Proteins/metabolism , Mice , Microscopy, Confocal , Molecular Sequence Data , Perciformes/metabolism , Phylogeny , Protein Binding , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Spleen/cytology , Transcriptome
7.
Biochem Biophys Res Commun ; 438(1): 236-41, 2013 Aug 16.
Article in English | MEDLINE | ID: mdl-23891694

ABSTRACT

The abundant proteins in human milk have been well characterized and are known to provide nutritional, protective, and developmental advantages to both term and preterm infants. Due to the difficulties associated with detection technology of the peptides, the expression of the peptides present in human milk is not known widely. In recent years, peptidome analysis has received increasing attention. In this report, the analysis of endogenous peptides in human milk was done by mass spectrometry. A method was also developed by our researchers, which can be used in the extraction of peptide from human milk. Analysis of the extracts by LC-MS/MS resulted in the detection of 1000-3000Da peptide-like features. Out of these, 419 peptides were identified by MS/MS. The identified peptides were found to originate from 34 proteins, of which several have been reported. Analysis of the peptides' cleavage sites showed that the peptides are cleaved with regulations. This may reflect the protease activity and distribution in human body, and also represent the biological state of the tissue and provide a fresh source for biomarker discovery. Isotope dimethyl labeling analysis was also used to test the effects of premature delivery on milk protein composition in this study. Differences in peptides expression between breast milk in term milk (38-41weeks gestation) and preterm milk (28-32weeks gestation) were investigated in this study. 41 Peptides in these two groups were found expressed differently. 23 Peptides were present at higher levels in preterm milk, and 18 were present at higher levels in term milk.


Subject(s)
Milk Proteins/analysis , Milk Proteins/chemistry , Milk, Human/chemistry , Premature Birth/metabolism , Proteome/analysis , Proteome/chemistry , Chromatography, Liquid/methods , Humans , Peptidomimetics/analysis , Peptidomimetics/chemistry , Tandem Mass Spectrometry/methods , Ultracentrifugation
8.
Fish Shellfish Immunol ; 33(5): 1133-8, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22982335

ABSTRACT

In mammals, interferon-γ-inducible-lysosomal thiol reductase (GILT) has been demonstrated to play a key role in the processing and presentation of MHC class II-restricted antigen (Ag) by catalyzing disulfide bond reduction, thus unfolding native protein Ag and facilitating subsequent cleavage by proteases. Here, we reported the cloning of a GILT gene homologue from zebrafish (zGILT), a tropical freshwater fish. The full-length cDNA of zGILT gene is 768 nucleotides (nt) encoding a protein of 255 amino acids (aa), with a putative molecular weight of 28.33 kDa. The deduced protein is highly homologous to that of fish and mammalian GILTs and shares 57.1% sequence identity to that of Atlantic salmon and 55.7-21.6% sequence identity to that of various mammals. The deduced protein possesses all the main features characteristic of known GILT proteins including the signature sequence CQHGX2ECX2NX4C spanning residues 117-132, CXXC motif at residues 72-75, one potential sites for N-linked glycosylation at residual positions 54. The zGILT expression is obviously up-regulated in spleen and kidney after immunization with LPS although it also is constitutively expressed in heart, liver, muscle and intestine, suggesting that zGILT may be involved in the immune response to bacterial challenge. The soluble recombinant protein was successfully purified using Ni-nitrilotriacetic acid resin. Recombinant His-zsGILT appeared on SDS-PAGE in the ranges of their estimated size of 18.94-kDa. After purification, further study revealed that zsGILT was capable of catalyzing the reduction of the interchain disulfide bonds intact IgG. These results will allow for further investigation to unravel the role of this key enzyme in class II MHC-restricted antigen processing and to use zebrafish as an in vivo model for related studies.


Subject(s)
Antigen Presentation/immunology , Gene Expression Regulation/immunology , Oxidoreductases Acting on Sulfur Group Donors/genetics , Oxidoreductases Acting on Sulfur Group Donors/metabolism , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism , Zebrafish/genetics , Analysis of Variance , Animals , Antigen Presentation/genetics , Base Sequence , Blotting, Western , DNA Primers/genetics , Electrophoresis, Polyacrylamide Gel , Gene Expression Regulation/genetics , Immunoglobulin G/metabolism , Kidney/metabolism , Lipopolysaccharides , Molecular Sequence Data , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Sequence Homology , Species Specificity , Spleen/metabolism , Zebrafish/immunology
9.
Mol Biol Rep ; 39(5): 6123-32, 2012 May.
Article in English | MEDLINE | ID: mdl-22246941

ABSTRACT

Here we describe the identification of the hedgehog Erinaceus europaeus homologue of a proliferation-inducing ligand (APRIL) of the TNF family (designated heAPRIL). Hedgehog APRIL contains two cysteine residues (Cys(196) and Cys(211)), a furin protease cleavage site and a conserved putative N-glycosylation site (Asn(124)). Real-time quantitative PCR (qPCR) analysis revealed that heAPRIL could be detected in various tissues. MTT assays and flow cytometric analysis revealed that Nus-hesAPRIL and hesAPRIL could promote the survival/proliferation of splenic B cells. Laser scanning confocal microscopy analysis showed GFP-hesAPRIL could successfully bind to the APRIL receptors of lymphocytes.


Subject(s)
Gene Expression Regulation , Hedgehogs/genetics , Tumor Necrosis Factor Ligand Superfamily Member 13/genetics , Amino Acids/metabolism , Animals , B-Lymphocytes/cytology , Cell Proliferation , Cell Survival , Cloning, Molecular , Gene Expression Profiling , Humans , Mice , Mice, Inbred ICR , Microscopy, Confocal , Microscopy, Fluorescence , Molecular Sequence Data , Organ Specificity/genetics , Protein Binding , RNA, Messenger/genetics , RNA, Messenger/metabolism , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Spleen/cytology , Structural Homology, Protein , Tumor Necrosis Factor Ligand Superfamily Member 13/chemistry , Tumor Necrosis Factor Ligand Superfamily Member 13/metabolism
10.
Amino Acids ; 42(6): 2393-402, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21805135

ABSTRACT

The increasing resistance of bacteria and fungi to currently available antibiotics is a major concern worldwide, leading to enormous efforts to develop new antibiotics with new modes of actions. Antibacterial peptide CM4 (ABP-CM4) is a small cationic peptide with broad-spectrum activities against bacteria, fungi, and tumor cells, which may possibly be used as a promising candidate for a new antibiotic. For pharmaceutical applications, a large quantity of antimicrobial peptides needs to be produced economically. In this communication, the progress in the structural characteristics, heterologous production, and biological evaluation of ABP-CM4 are reviewed.


Subject(s)
Antimicrobial Cationic Peptides/biosynthesis , Recombinant Fusion Proteins/biosynthesis , Amino Acid Sequence , Anti-Infective Agents/metabolism , Anti-Infective Agents/pharmacology , Antimicrobial Cationic Peptides/genetics , Antimicrobial Cationic Peptides/pharmacology , Circular Dichroism , Cloning, Molecular , Escherichia coli/drug effects , Escherichia coli/genetics , Escherichia coli/metabolism , Fungi/drug effects , Gene Expression , Humans , Microbial Sensitivity Tests , Models, Molecular , Molecular Sequence Data , Pichia/genetics , Pichia/metabolism , Protein Structure, Secondary , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/pharmacology
11.
Int Immunopharmacol ; 12(1): 34-41, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22032840

ABSTRACT

Members of the tumor necrosis factor (TNF) family play key roles in the regulation of inflammation, immune responses and tissue homeostasis. Here we describe the identification of the Japanese sea perch (Lateolabrax japonicus) homologue of mammalian B cell activating factor of the TNF family (BAFF/BLyS) (designated LjBAFF). The cDNA contains an open reading frame (ORF) of 783 nucleotides that are translated into a predicted 260 amino acid protein. Like most known BAFFs, Japanese sea perch BAFF contains three cysteine residues (Cys(123), Cys(218) and Cys(232)) which are conserved in the aligned BAFF sequences and a furin protease cleavage site (R-K-K-R). Real-time quantitative PCR (qPCR) analysis revealed that LjBAFF could be detected in various tissues and predominantly expressed in lymphoid tissue spleen. The soluble BAFF (LjsBAFF) had been cloned into a pET28a vector to express the recombinant protein. The His-LjsBAFF was efficiently expressed in Escherichia coli BL21 (DE3) and its expression was confirmed by SDS-PAGE and Western blotting analysis. After purification, MTT assays and flow cytometric analysis revealed that LjsBAFF could promote the survival/proliferation of splenic B cells in vitro. Furthermore, bacterially expressed LjsBAFF induced the selective expansion of B cells in the spleen when administered to young mice. Our results suggest that like its mammalian counterparts, LjsBAFF plays an important role in the survival and/or proliferation of B cells.


Subject(s)
B-Cell Activating Factor/genetics , B-Cell Activating Factor/immunology , Perches/genetics , Amino Acid Sequence , Animals , B-Cell Activating Factor/pharmacology , B-Lymphocytes/cytology , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , Cell Proliferation/drug effects , Cell Survival/drug effects , Cloning, Molecular , DNA, Complementary/genetics , Escherichia coli/genetics , Gene Expression , Lymphocyte Count , Mice , Molecular Sequence Data , Perches/immunology , Phylogeny , RNA, Messenger/metabolism , Recombinant Proteins/immunology , Recombinant Proteins/pharmacology , Sequence Alignment , Spleen/cytology , Spleen/drug effects , Spleen/immunology , Tissue Distribution
12.
Protein J ; 30(8): 592-7, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22057545

ABSTRACT

Bone morphogenetic proteins (BMPs) are cytokines from the TGF-ß superfamily, with important roles during embryonic development and in the induction of bone and cartilage tissue differentiation in the adult body. In this contribution, We report here the application of small ubiquitin-related modifier (SUMO) fusion technology to the expression and purification of human BMP-14. The fusion protein expressed in a soluble form was purified to a purity of 90% by Ni-IDA chromatography. After the SUMO-BMP14 fusion protein was cleaved by the SUMO protease at 30 °C for 1 h, the cleaved sample was re-applied to a Ni-IDA. Finally, about 45 mg recombinant hBMP-14 was obtained from 1 litre bacterial culture with no less than 95% purity. The purified hBMP-14 dimer was over 90% purity and could induce the expression of alkaline phosphatase activity in C2C12 cells in a dose-dependent manner. Thus the SUMO-mediated peptide expression and purification system potentially could be employed for the production of other homodimeric proteins.


Subject(s)
Escherichia coli/genetics , Gene Expression , Growth Differentiation Factor 5/genetics , Growth Differentiation Factor 5/metabolism , Small Ubiquitin-Related Modifier Proteins/genetics , Escherichia coli/metabolism , Growth Differentiation Factor 5/isolation & purification , Humans , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Small Ubiquitin-Related Modifier Proteins/isolation & purification , Small Ubiquitin-Related Modifier Proteins/metabolism
13.
Int Immunopharmacol ; 11(12): 2091-7, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21951863

ABSTRACT

In this study, an interferon-γ-inducible-lysosomal thiol reductase (GILT) homologue has been cloned and identified from South African clawed frog Xenopus laevis (designated XlGILT). The open reading frame (ORF) of XlGILT consists of 771 bases encoding a protein of 256 amino acids with an estimated molecular mass of 28.76kDa and a theoretical isoelectric point of 5.12. The N-terminus of the XlGILT was found to have a putative signal peptide with a cleavage site amino acid position at 15-16. SMART analysis showed that the XlGILT contained a GILT active-site C(69)GGC(72) motif and a GILT signature motif C(114)QHGKEECIGNLIETC(129). The expression levels of XlGILT mRNA were higher in spleen and peripheral blood mononuclear cells (PBMCs), moderate in liver, intestine, heart and kidney, and lower in lung. The XlGILT mRNA expression was significantly up-regulated in spleen in vivo and PBMCs in vitro after LPS stimulation. The soluble X. laevis GILT (XlsGILT) was inserted into a pET28a vector and expressed in BL21 (DE3) cells as a His-tag fusion enzyme. After purification, further study revealed that XlsGILT was capable of catalyzing the reduction of the interchain disulfide bonds intact IgG. These results will allow for further investigation to unravel the role of this key enzyme in class II MHC-restricted antigen processing and to use X. laevis as an in vivo model for related studies.


Subject(s)
Gene Expression , Lysosomes/enzymology , Oxidoreductases Acting on Sulfur Group Donors/genetics , Xenopus Proteins/genetics , Xenopus laevis/genetics , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Cells, Cultured , Cloning, Molecular , Genetic Vectors , Intestinal Mucosa/metabolism , Kidney/metabolism , Leukocytes, Mononuclear/metabolism , Liver/metabolism , Lung/metabolism , Lysosomes/genetics , Molecular Sequence Data , Myocardium/metabolism , Open Reading Frames/genetics , Oxidoreductases/biosynthesis , Oxidoreductases/genetics , Recombinant Fusion Proteins/biosynthesis , Sequence Analysis, DNA , Spleen/metabolism
14.
Dev Comp Immunol ; 34(11): 1199-208, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20600273

ABSTRACT

A novel bovine cDNA has been isolated by EST assembly and subsequently confirmed by using RT-PCR and designated bovine A Proliferation-Inducing Ligand belonging to TNF family (bAPRIL). The open reading frame (ORF) of this cDNA covers 753 bp, encoding 250 amino acids. The functional soluble part of bAPRIL (bsAPRIL) shows 97% and 92% identity with its pig and human counterparts, respectively, at the level of the primary protein structure. The bAPRIL genomic sequence consists of six exons and five introns, is approximately 1.8 kb in size, and maps to bovine chromosome 19q. Real-time quantitative PCR (qPCR) analysis revealed that bAPRIL is predominantly expressed in bovine lymphoid tissues spleen. The predicted three-dimensional (3D) structure of the bsAPRIL monomer analyzed by "comparative protein modelling" revealed that it is very similar to its mouse counterpart. The bsAPRIL and EGFP/bsAPRIL were efficiently expression in Escherichia coli BL21 (DE3) and its expression was confirmed by SDS-PAGE and Western blotting analysis. After purification, the EGFP/bsAPRIL fusion protein obtained similar fluorescence spectrum to those of EGFP. Laser scanning confocal microscopy analysis showed EGFP/bsAPRIL could bind to its receptor. In vitro, bsAPRIL could promote the proliferation of bovine or mouse splenic B cells together with/without SAC or anti-mouse IgM. Furthermore, compared to mouse soluble APRIL, the bovine soluble APRIL has the similar proliferation to mouse B cell. Those findings indicated that bsAPRIL plays an important role in proliferation of bovine B cells and has functional cross-reactivity among cow and other mammalians. Therefore, APRIL may be a potential immunologic factor for enhancing immunological efficacy in animals.


Subject(s)
B-Lymphocytes/metabolism , Cattle , Recombinant Fusion Proteins/metabolism , Spleen/metabolism , Tumor Necrosis Factor Ligand Superfamily Member 13/metabolism , Amino Acid Sequence , Animals , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Biological Evolution , Cell Proliferation , Cloning, Molecular , Gene Expression Profiling , Humans , Immunization , Mice , Molecular Sequence Data , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/isolation & purification , Spleen/cytology , Spleen/immunology , Structural Homology, Protein , Tumor Necrosis Factor Ligand Superfamily Member 13/genetics , Tumor Necrosis Factor Ligand Superfamily Member 13/immunology , Tumor Necrosis Factor Ligand Superfamily Member 13/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...